Anti-tumor agent containing anti-tumor platinum complex, and anti-tumor effect enhancer

In order to provide a novel cancer treatment method using a FTD⋅TPI combination drug that exhibits markedly excellent anti-tumor effects with fewer side effects, the present invention provides an anti-tumor agent characterized in that the FTD⋅TPI combination drug and an anti-tumor platinum complex are administered in combination..

Medienart:

Patent

Erscheinungsjahr:

2018

Erschienen:

2018

Enthalten in:

Europäisches Patentamt - (2018) vom: 09. Okt. Zur Gesamtaufnahme - year:2018

Sprache:

Englisch

Beteiligte Personen:

OKABE HIROYUKI [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2018-10-09, Last update posted on www.tib.eu: 2023-10-11, Last updated: 2023-10-20

Patentnummer:

US10092589

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA004365151